Home・Listă Acțiuni・Stryker Corp

Stryker Corp

Deschisă

SectorSănătate

337.76 -0.9

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

334.39

Maxim

341.74

Indicatori cheie
By Trading Economics
Venit	531M 1.3B
Vânzări	569M 6.6B
P/E Medie Sector	35.072 57.002
EPS	3.69
Randament dividend	1.03
Marjă de profit	19.366
Angajați	56,000
EBITDA	266M 1.6B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+12.82% upside

Dividende
By Acuity
Randament dividend Medie Sector	1.03% 2.22%
Următoarele câștiguri	29 oct. 2026
Data viitoare de dividende	30 oct. 2026
Următoarea dată ex-dividende	29 sept. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	3.6B 133B
Deschiderea anterioară	338.66
Închiderea anterioară	337.76

Sentimentul știrilor

By Acuity

61%

39%

296 / 340 Clasament în Healthcare

Stryker Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 aug. 2026, 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12 aug. 2026, 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11 aug. 2026, 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10 aug. 2026, 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7 aug. 2026, 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

6 aug. 2026, 20:06 UTC

Macro Event

News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

5 aug. 2026, 23:12 UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

4 aug. 2026, 19:56 UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

3 aug. 2026, 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31 iul. 2026, 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30 iul. 2026, 23:41 UTC

Social Media

News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29 iul. 2026, 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28 iul. 2026, 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27 iul. 2026, 19:06 UTC

Social Media

News

Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24 iul. 2026, 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22 iul. 2026, 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21 iul. 2026, 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20 iul. 2026, 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Comparație

Modificare preț

Stryker Corp Așteptări

Obiectiv de preț

By TipRanks

12.82% sus

Prognoză pe 12 luni

Medie 384.82 USD 12.82%

Maxim 455 USD

Minim 340 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruStryker Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 18 analiști care au acordat evaluări ale acțiunilor Stryker Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

296 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.